IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Fcpm III Services B.V.

Portfolio Profile

CIK: 0002013410 | NAARDEN, P7

Investment Profile

Style

Deep Value

Turnover

Medium

Orientation

Concentrated trader
$750.4M
AUM
11
Positions
99.89%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Newamsterdam Pharma Company(NAMS)8,490,353$287.7M38.34%
2Maplight Therapeutics Inc(MPLT)3,226,400$115.6M15.41%
3Dyne Therapeutics Inc(DYN)3,848,256$85.5M11.39%
4VOR Biopharma Inc(VOR)4,117,354$75.8M10.10%
5Damora Therapeutics Inc(GLTO)2,441,000$63.5M8.46%

Sector Allocation

Latest filing, equity positions only

Unclassified53.86% · $404.2M
Healthcare46.14% · $346.2M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare49.14%46.14%-3%
Unclassified50.86%53.86%+3%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$339.4M | 9 pos.
$707.3M | 10 pos.
$678.1M | 11 pos.
$582.3M | 11 pos.
$592.4M | 12 pos.
$413.7M | 12 pos.
6
Replimune Group Inc(REPL)
2,808,368
$31.1M
4.14%
7Crescent Biopharma Inc.(CBIO)1,677,852$30.2M4.02%
8Aura Biosciences Inc(AURA)4,053,775$28.8M3.84%
9Engene Holdings Inc(ENGN)9,632,561$16.7M2.22%
10Bicycle Therapeutics PLC(BCYC)3,468,430$14.7M1.96%
Cap SizePrev %Curr %Change
Unclassified50.86%53.86%+3%
Small Cap37.48%34.75%-2.73%
Mid Cap11.66%11.39%-0.27%
$369.2M | 12 pos.
$500.4M | 13 pos.
$762.9M | 14 pos.
$722.2M | 14 pos.
$750.4M | 15 pos.
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

1
New
0
Closed
0
Increased
2
Decreased
8
Unchanged